Definitive Healthcare (NASDAQ:DH) Issues Q1 2024 Earnings Guidance theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Definitive Healthcare's Q4 2023 performance, with adjusted EPS at $0.07, sales of $65.93 million, and a 5% Y/Y growth in enterprise clients. Get insights into Q1 2024 guidance and fiscal year 2024 expectations, despite macroeconomic challenges. Analysts note resilience and positive developments, maintaining an Outperform rating.
Definitive Healthcare (NASDAQ:DH – Get Free Report) issued an update on its first quarter earnings guidance on Wednesday morning. The company provided EPS guidance of $0.07-0.08 for the period, compared to the consensus EPS estimate of $0.07. The company issued revenue guidance of $63-65 million, compared to the consensus revenue estimate of $65.95 million. Definitive […]